Financial reports
ARS
2024 FY
Annual report to shareholders
7 Jun 24
10-K
2024 FY
Annual report
20 May 24
10-Q
2024 Q3
Quarterly report
8 Feb 24
10-Q
2024 Q2
Quarterly report
2 Nov 23
10-Q
2024 Q1
Quarterly report
8 Aug 23
ARS
2023 FY
Annual report to shareholders
16 Jun 23
10-K
2023 FY
Annual report
22 May 23
10-Q
2023 Q3
Quarterly report
7 Feb 23
10-Q
2023 Q2
Quarterly report
8 Nov 22
10-Q
2023 Q1
Quarterly report
10 Aug 22
Current reports
8-K
Entry into a Material Definitive Agreement
29 May 24
8-K
Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
23 May 24
8-K
Haemonetics Announces Proposed Convertible Senior Notes Offering
21 May 24
8-K
Results of Operations and Financial Condition
9 May 24
8-K
Entry into a Material Definitive Agreement
1 May 24
8-K
Haemonetics Corporation Completes Acquisition of Attune Medical
1 Apr 24
8-K
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
5 Mar 24
8-K
Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2024 Results; Updates Fiscal 2024 Guidance
8 Feb 24
8-K
Other Events
12 Dec 23
8-K
Haemonetics Reports Second Quarter and First Half Fiscal 2024 Results; Updates Fiscal 2024 Guidance
2 Nov 23
Registration and prospectus
S-8
Registration of securities for employees
11 Aug 23
POS AM
Prospectus update (post-effective amendment)
30 Jul 19
S-8
Registration of securities for employees
30 Jul 19
S-8
Registration of securities for employees
5 Feb 18
S-8
Registration of securities for employees
14 Nov 14
S-8
Registration of securities for employees
1 Jun 12
SC TO-T/A
Third party tender offer statement (amended)
1 Apr 10
SC TO-T/A
Third party tender offer statement (amended)
25 Mar 10
SC TO-T/A
Third party tender offer statement (amended)
18 Mar 10
SC TO-T/A
Third party tender offer statement (amended)
11 Mar 10
Proxies
DEFA14A
Additional proxy soliciting materials
7 Jun 24
DEF 14A
Definitive proxy
7 Jun 24
DEFA14A
Additional proxy soliciting materials
16 Jun 23
DEF 14A
Definitive proxy
16 Jun 23
DEFA14A
Additional proxy soliciting materials
17 Jun 22
DEF 14A
Definitive proxy
17 Jun 22
DEFA14A
Additional proxy soliciting materials
17 Jun 21
DEF 14A
Definitive proxy
17 Jun 21
DEFA14A
Additional proxy soliciting materials
30 Jun 20
DEFA14A
Additional proxy soliciting materials
8 Jun 20
Other
SD
Conflict minerals disclosure
28 May 24
SD
Conflict minerals disclosure
30 May 23
SD
Conflict minerals disclosure
26 May 22
SD
Conflict minerals disclosure
28 May 21
SD
Conflict minerals disclosure
29 May 20
EFFECT
Notice of effectiveness
12 Aug 19
SD
Conflict minerals disclosure
30 May 19
CT ORDER
Confidential treatment order
19 Feb 19
SD
Conflict minerals disclosure
30 May 18
CT ORDER
Confidential treatment order
28 Aug 17
Ownership
4
Christopher Simon,
7 Jun 24
4
Anila Lingamneni
29 May 24
4
Josep Llorens
29 May 24
4
Michelle L Basil
29 May 24
4
Laurie A. Miller
29 May 24
4
Christopher Simon,
29 May 24
4
Stewart W Strong
29 May 24
144
Notice of proposed sale of securities
29 May 24
144
Notice of proposed sale of securities
29 May 24
4
Farris Maryanne Maunsell
21 May 24